Canada Pension Plan Investment Board’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Canada Pension Plan Investment Board's PBYI Position: Q3 2026 in Review
Canada Pension Plan Investment Board increased its Puma Biotechnology (PBYI) stake by 21% in Q3 2026, buying an estimated $137K and bringing the position to 89,100 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.
Canada Pension Plan Investment Board first reported a position in PBYI in Q1 2015 and has held it in 21 quarters since. The position peaked at $3.75M in Q2 2017. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Canada Pension Plan Investment Board held 89,100 shares of Puma Biotechnology worth $885K as of Q3 2026.
- Canada Pension Plan Investment Board bought 15,600 Puma Biotechnology shares in Q3 2026, an estimated $137K.
- Puma Biotechnology made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q3 2026, its #1039 holding.
- Canada Pension Plan Investment Board first reported a position in Puma Biotechnology in Q1 2015 and has held it in 21 quarters since.
- Canada Pension Plan Investment Board's Puma Biotechnology position peaked at $3.75M in Q2 2017.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q3 2026, filed 16 Nov 2026.